Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Odin

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Frontiers in Aging Neuroscience|June 17, 2026
Overcoming the diagnostic gap in mild cognitive impairment in Parkinson's disease: a pilot study employing a machine learning-/augmented reality-based digital biomarkerKarolina Poplawska-Domaszewicz, Emmanuel Streel, Aleksandra Brek, et al.
Neurology and Therapy|January 11, 2022
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 CountriesAngelo Antonini, Rajesh Pahwa, Per Odin, et al.
BMC Neurology|January 25, 2022
Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countriesIrene A Malaty, Pablo Martinez-Martin, K Ray Chaudhuri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 30, 2014
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label resultsHubert H Fernandez, David G Standaert, Robert A Hauser, et al.
Journal of Parkinson'S Disease|May 5, 2025
Early thinking palliative care for people with Parkinson's disease: A thematic synthesis based on a systematic mixed-methods reviewMichela Garon, Christiane Weck, Valentina Leta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 21, 2006
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest studyKallol Ray Chaudhuri, Pablo Martinez-Martin, Anthony H V Schapira, et al.
Movement Disorders Clinical Practice|January 16, 2026
Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's DiseaseK Ray Chaudhuri, Bruno Bergmans, Eric Freire-Alvarez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 4, 2007
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot studyKallol Ray Chaudhuri, Pablo Martinez-Martin, Richard G Brown, et al.
Movement Disorders Clinical Practice|December 3, 2025
Documented End-of-Life Preferences of People With Parkinson's Disease or Parkinsonism Across EuropeBauke W Dijkstra, Catharina Muente, Michela Garon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trialsAnthony E Lang, Ramon L Rodriguez, James T Boyd, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Frontiers in Aging Neuroscience|June 17, 2026
Overcoming the diagnostic gap in mild cognitive impairment in Parkinson's disease: a pilot study employing a machine learning-/augmented reality-based digital biomarkerKarolina Poplawska-Domaszewicz, Emmanuel Streel, Aleksandra Brek, et al.
Neurology and Therapy|January 11, 2022
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 CountriesAngelo Antonini, Rajesh Pahwa, Per Odin, et al.
BMC Neurology|January 25, 2022
Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countriesIrene A Malaty, Pablo Martinez-Martin, K Ray Chaudhuri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 30, 2014
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label resultsHubert H Fernandez, David G Standaert, Robert A Hauser, et al.
Journal of Parkinson'S Disease|May 5, 2025
Early thinking palliative care for people with Parkinson's disease: A thematic synthesis based on a systematic mixed-methods reviewMichela Garon, Christiane Weck, Valentina Leta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 21, 2006
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest studyKallol Ray Chaudhuri, Pablo Martinez-Martin, Anthony H V Schapira, et al.
Movement Disorders Clinical Practice|January 16, 2026
Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's DiseaseK Ray Chaudhuri, Bruno Bergmans, Eric Freire-Alvarez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 4, 2007
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot studyKallol Ray Chaudhuri, Pablo Martinez-Martin, Richard G Brown, et al.
Movement Disorders Clinical Practice|December 3, 2025
Documented End-of-Life Preferences of People With Parkinson's Disease or Parkinsonism Across EuropeBauke W Dijkstra, Catharina Muente, Michela Garon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trialsAnthony E Lang, Ramon L Rodriguez, James T Boyd, et al.
Pageof 17